Health Catalyst — Third Quarter 2026 Earnings Summary

Health Catalyst reported third-quarter 2026 total revenue of $56.3 million, a 26% decrease from the prior year, driven primarily by the divestiture of its Vitalware Business and migration headwinds. The company recorded a net income of $40.5 million for the quarter, largely attributable to a $65.9 million gain on the sale of the Vitalware Business. Adjusted EBITDA for the period was $0.8 million, reflecting a 94% year-over-year decline. Despite the revenue contraction, Health Catalyst reaffirmed its full-year 2026 guidance, projecting total revenue between $246 million and $249 million and Adjusted EBITDA between $18 million and $18.5 million.